Publications by authors named "Yusuke Fujieda"

Claim this Profile
A
An Association between HTRA1 and TGF-β in the Vitreous Humor of Patients with Chorioretinal Vascular Diseases.
Yoko Fukushima, Shizuka Takahashi, Machiko Nakamura, Tatsuya Inoue, Yusuke Fujieda

J Clin Med· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A splice-switching oligonucleotide treatment ameliorates glycogen storage disease type 1a in mice with G6PC c.648G>T.
Kentaro Ito, Go Tajima, Chikako Kamisato, Miyuki Tsumura, Mitsuhiro Iwamoto, Yusuke Fujieda

J Clin Invest· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel mouse model for evaluating in vivo efficacy of xCT inhibitor.
Ryosuke Yoshioka, Yusuke Fujieda, Yamato Suzuki, Osamu Kanno, Asako Nagahira

J Pharmacol Sci· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design, synthesis, and biological evaluation of 3-(1-Aryl-1H-indol-5-yl)propanoic acids as new indole-based cytosolic phospholipase A2α inhibitors.
Toshiyuki Tomoo, Takashi Nakatsuka, Toyoko Katayama, Yasuhiro Hayashi, Yusuke Fujieda

J Med Chem· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inflammation and resolution are associated with upregulation of fatty acid β-oxidation in Zymosan-induced peritonitis.
Yusuke Fujieda, Atsushi Manno, Yasuhiro Hayashi, Nelson Rhodes, Lining Guo

PLoS One· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metabolite profiles correlate closely with neurobehavioral function in experimental spinal cord injury in rats.
Yusuke Fujieda, Shinya Ueno, Ryoko Ogino, Mariko Kuroda, Thomas J Jönsson

PLoS One· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetic/pharmacodynamic analyses of chymase inhibitor SUN13834 in NC/Nga mice and prediction of effective dosage for atopic dermatitis patients.
Atsuto Ogata, Yusuke Fujieda, Maki Terakawa, Tsuyoshi Muto, Taisaku Tanaka

Int Immunopharmacol· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oral chymase inhibitor SUN13834 ameliorates skin inflammation as well as pruritus in mouse model for atopic dermatitis.
Maki Terakawa, Yusuke Fujieda, Yoshiaki Tomimori, Tsuyoshi Muto, Taisaku Tanaka

Eur J Pharmacol· December 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis